Effects of lambda-carrageenan induced experimental enterocolitis on splenocyte function and nitric oxide production

Journal of Surgical Research

Volumn 66, Issue 1, 1996, Pages 6-11

  Pricolo, Victor E ^a   Madhere, Shirley M ^a   Finkelstein, Sidney D ^b   Reichner, Jonathan S ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENTEROCOLITIS; HISTOPATHOLOGY; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; SPLEEN FUNCTION; SPLEEN LYMPHOCYTE;

EID: 0030294591     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0364     Document Type: Article

References (20)

1. 1. Strober, W., and Ehrhardt, R. O. Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75: 203, 1993.
2. 2. Warren, B. F., and Watkins, P. E. Animal models of inflammatory bowel disease. J. Pathol. 172: 313, 1994.
3. 3. Yamada, T., Marshall, S., Specian, R. D., and Grisham, M. B. A comparative analysis of two models of colitis in rats. Gastroenterology 102: 1524, 1992.
4. 4. Moyana, T. N., and Lalonde, J-MA. Carrageenan-induced intestinal injury in the rat - A model for inflammatory bowel disease. Ann. Clin. Lab. Sci. 20: 420, 1990.
5. 5. Moyana, T. N., and Lalonde, J-MA. Carrageenan-induced intestinal injury: possible role of oxygen free radicals. Ann. Clin. Lab. Sci. 21: 258, 1991.
6. 6. Gross, V., Arndt, H., and Andus, T., Palitzsch, K. D., and Scholmerich, J. Free radicals in inflammatory bowel diseases -Pathophysiology and therapeutic implications. Hepato-gastroenterol. 41: 320, 1994.
7. 7. Stark, M. E., and Szurszewski, J. H. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103: 1928, 1992.
8. 8. Goldstein, I. J., and Hayes, C. E. The lectins: Carbohydrate-binding proteins of plants and animals. Adv. Carbohydr. Chem. Biochem. 35: 127, 1978.
9. 9. Ding, A. H., Nathan, C. F., and Stuehr, D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141: 2407, 1988.
10. 10. Selby, W. S., Janossy, G., Bofill, M., and Jewell, D. P. Intestinal lymphocyte subpopulations in inflammatory bowel disease: An analysis by immunohistological and cell isolation techniques. Gut 25: 32, 1984.
11. 11. Podolsky, D. K. Inflammatory bowel disease. N. Engl. J. Med. 325(13): 928 (14): 1008, 1991.
12. 11. Podolsky, D. K. Inflammatory bowel disease. N. Engl. J. Med. 325(13): 928 (14): 1008, 1991.
13. 12. Brandtzaeg, P., Halstensen, T. S., Kett, K., Krajci, P., Kvale, D., Rognum, T. O., Scott, P., and Sollid, L. M. Immunobiology and immunolpathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes. Gastroenterology 97: 1562, 1989.
14. 13. Seago, N. D., Thompson, J. H., Zhang, X-J., Eloby-Childress, S., Sadowska-Krowicka, H., Rossi, J. L., Currie, M. G., Manning, P. T., Clark, D. A., and Miller, M. J. S. Inducible nitric oxide synthase and guinea-pig ileitis induced by adjuvant. Mediators Inflammation 4: 19, 1995.
15. 14. van Dijk, A. P. M., Keuskamp, Z. J., Wilson, J. H. P., and Zijlstra, F. J. Sequential release of cytokines, lipid mediators and nitric oxide in experimental colitis. Mediators Inflammation 4: 186, 1995.
16. 15. Oudkerk Pool, M., Bouma, G., Visser, J. J., Kolkman, J. J., Tran, D. D., Meuwissen, S. G. M., and Pena, A. S. Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand. J. Gastroenterol. 30: 784, 1995.
17. 16. Albina, J. E., and Henry, W. L. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 50: 403, 1991.
18. 17. Grisham, M. B., Specian, R. D., and Zimmerman, T. E. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J. Pharmacol. Exp. Ther. 271: 1114, 1994.
19. 18. Rachmilewitz, D., Karmeli, F., Okon, E., and Bursztyn, M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37: 247, 1995.
20. 19. Hogaboam, C. M., Jacobson, K., Collins, S. M., and Blennerhassett, M. G. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am. J. Physiol. 268: G673, 1995.